Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 7.8× sales vs its 1366.3× historical median P/S.
Fair value ≈ $874.93 · price $4.97 today
Undervalued · 99% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$BLUE $QURE this @MF_DOOM character is a options player ..believe nothing he says …he has been here before touting higher prices and leaves when this hits $30 ..( use to be $25 ) so his rhetoric is garbage…
$QURE go long kid, I was thinking BO around $80-100 but we may not even need a BO for that price point to be obtainable now but I do still think a BO is possible and on the table here in the long term…let’s see as more time passes
$BLUE $CRSP
$SPY $QQQ
$BLUE sounds like $BCRX woke grifters scamming the system sending money back to Pakistan to be used to subvert America. Supported by woke terrorists that want to subvert America. Show them what America is made of Wall Street. If this company wasn't all about scamming the system for money it would be working on drugs for important conditions like ARDS which just took American hero Kyle Busch
@techjerk @Capitalistpig57 I believe you, and I understand you because I’ve been through similar situations myself. The latest one was with $BLUE, where I lost $15K in exactly the same way.
The important thing is to keep your mental balance and keep going. What doesn’t kill you makes you stronger, as they say :)
Stay strong! True wealth lies in the spirit.
$CADL $TNXP $BLUE @FastFreddy69 MAGA’s are the new tds
They never got their low gas prices , nor lower interest rates
And “ no wars “ …you voted for a retard !! i knew it , you were conned bother with Trump , Tak , Seth and Nick !
$CADL $TNXP $BLUE forgot to add Nick Leschly , CEO of the failed bluebird bio and recently fcuked up $TSVT . He too lied to the street , as TAK has and continues to do, and like NICK, Wall Street will fcuk him over .
@free2dream you sadly can kill some bio tech innovation aka $BLUE but Qure has a much better management team and is further along both internally and externally connected than blue ever was so I do think long term we see $80-100 range here or a possible BO years from now
@Yobro247 this has some good bones and connection with big companies why I was willing to double down at $10
I personally think the end goal with be a BO but the main reason this is short term trending is that the fda decision making on this was and is an example just how Wild West gene therapy is due to the complexity and costs
I don’t entirely think the individual on the board gets fired but I do know this is a cheap price and many want this unlike $BLUE which got STOLEN by $CG while completely screwing investors (like myself) Qure has better connections and history (Roche) it’s a solid company with a good pipeline it’s also much more possible for Qure to go full scale and do everything in-house but I do think they might buyout given enough time and a good enough offer
